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The majority (69%) were only found upon claims review. Pathway compliance for 
chemotherapy was 99% for the 250 regimens selected through the DST and 89% for 
the 548 regimens identified through claims analysis only (p < .05). CONCLUSIONS: 
Use of a real-time, point-of-care DST can significantly enhance pathway compli-
ance, but low adoption rates and usage limit the current benefit of this technology. 
Further research is needed to identify barriers to real-time, point-of-care DST adop-
tion, which include impact on workflow, redundancy to electronic medical record, 
and perceptions of intrusion.
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OBJECTIVES: To evaluate the distribution and costs of the deliveries made by the 
Unified Health System (Brazilian National Public Health System) in different regions 
of Brazil. METHODS: The data was obtained through the DATASUS database in the 
Hospital Information System searching for childbirth procedures codes between 
2008 and 2013. The population data were obtained from IBGE (Brazilian Institute of 
Geography and Statics). RESULTS: More than 11 million child deliveries were made 
through SUS between 2008 and 2013, totaling an expense of R$7,310,082,363.75 (an 
average of R$1,218,341,060.33 per year). Regarding the North, Northeast, Midwest, 
Southeast and, South regions and Overall Brazil, the indices were respectively: (1) 
Percentage of births in six years; 12%, 35%, 7%, 34%, 12% and 100%. (2) Percentage 
of spending on births in six years; 11%, 33%, 7%, 36%, 12% and 100%. (3) Number 
of births per 100,000 women between 10 and 49 years; 4,179.73, 3,454.16, 2,914.86, 
2,496.46, 2,668.76 and 2,970.01. (4) Ratio between GDP per capita and number of 
deliveries per 100,000 women between 10 and 49 years; 3,506, 3,080, 10,563, 11,982, 
9,757 and 7,402. There was a decrease in the number of births in the last 6 years 
from 3,247.08 / 100,000 in 2008 to 2,970.01 / 100,000 in 2013 (average reduction of 
1.76% / year). CONCLUSIONS: There was a decrease in the number of birth between 
2008 and 2013, with the largest number of births taking place in the regions with the 
lowest GDP per capita, especially North and Northeast Regions.
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OBJECTIVES: To determine the impact of MTM services on healthcare utilization 
and total healthcare expenditures. METHODS: A comprehensive community-based 
pharmacist-led MTM program was initiated among Texas Medicaid patients aged 
18-64 years with chronic hypertension, having at least 4 maintenance medications 
and who were continuously enrolled one year pre- and post-index (date of first MTM 
encounter). MTM data from participating pharmacies and Texas Medicaid medi-
cal and prescription claims were extracted from 4/28/2011-9/10/2014. Healthcare 
utilization and total expenditures were evaluated for a period of one-year pre- and 
post-index date. The primary outcomes were number of and expenditures on: inpa-
tient and outpatient claims (e.g., physician visits, outpatient procedures, laboratory 
tests) and prescriptions. Bivariate paired analyses were employed to compare out-
come variables pre- and post-MTM program implementation. RESULTS: Although 
141 patients received MTM services, 81 met the inclusion criteria. Patients were 
50.2±9.3 years old with the majority (83.9%) having between 1 and 4 MTM encoun-
ters in the one-year post-period. From pre- to post-, the proportion of inpatient 
claims decreased by 28.2% (from 30.9% to 22.2%; p= 0.26), but not significantly. The 
mean number of outpatient and prescription claims decreased significantly: by 
30.1% [82.62(±62.15) to 57.65(±48.82); (p< 0.0001)]; and by 13.5% [88.86(±66.49) to 
76.89(±67.66); (p= 0.043)], respectively. Total expenditures decreased significantly 
pre- to post by 31.4% from $27,543.15 (±$25,442.98) to $18,888.96 (±$21,429.53); 
(p< 0.0001). CONCLUSIONS: The Texas MTM pilot program demonstrated favorable 
economic outcomes. Total expenditures for patients with hypertension decreased 
significantly after MTM exposure. Although there were reduction in expenditures on 
inpatient, outpatient and prescription claims, provision of MTM services to Medicaid 
recipients may have the biggest impact on inpatient and outpatient healthcare 
utilization.
PHS144
cHaracteriSticS of drug tHeraPy ProBlemS and reSPonSe rate in 
telePHonic comPreHenSive medication reviewS Provided to 2014 
medicare Part d BeneficiarieS
Wong J.
Scott and White Health Plan, Temple, TX, USA
OBJECTIVES: In 2014, the state of Texas is home to over 26 million individuals, 
of which 11.2% are 65 years and older. The Centers for Medicare and Medicaid 
Services require health plan sponsors to provide interactive comprehensive medica-
tion reviews (CMRs) to eligible Medicare beneficiaries. Studies to date have demon-
strated clinical and economic outcomes in MTM services that have a collaborative 
practice agreement in place. Few studies have explored the outcomes of MTM ser-
vices, where the resolution of the drug therapy problem (DTP) is dependent upon 
the prescriber. METHODS: Retrospective review of electronic medical records and 
prescription claims data were conducted in patients with one MTM consult between 
January 1stand May 31st. Estimates and respective 95% confidence intervals were 
provided for the average number of DTPs, and for the percentages of each type of 
DTP’s and MTM services.  Continuous variables were described as mean (standard 
deviation) or median (min-max) as appropriate. Categorical variables were summa-
rized as counts (percentages). The number of DTPs per patient and resolution rate 
was calculated. A proportional odd model was fitted with generalized estimating 
equations. This model considered response as a multinomial ordinal response and 
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OBJECTIVES: To examine the predictors and trends in utilization of cervical cancer 
screening (CCS) in U.S. from 2006 to 2011. METHODS: A cross-sectional study was 
conducted using data from Medical Expenditure Panel Survey (MEPS) 2006 to 2011. 
The study included women eligible for CCS belonging to the age category 21-65 years 
according to the USPSTF prescribed guidelines. The use of Pap smear test was the 
outcome of interest. The independent variables were categorized into predisposing, 
enabling, and need characteristics according to the Andersen Behavioral Model of 
Health Services Utilization. Descriptive statistics and chi-square tests were per-
formed to examine group differences. Multivariate logistic regression and trend 
analysis were performed to investigate the effect of independent factors on CCS 
use and the yearly change in the rate of CCS, respectively. RESULTS: A total of 
547,749,778 women with an average age of 42.6 years constituted the study cohort 
of which 80.39% received screening. Most of them were Whites (65.61%), followed by 
Blacks (13.18%) and Hispanics (14.57%). Result from the logistic regression indicated 
that women who were married (OR: 3.53, 95%CI: 2.97-4.20) and divorced (OR: 3.98, 
95%CI: 2.88-5.50) were more likely to receive screening compared to unmarried 
ones. Older women (OR: 1.05, 95%CI: 1.04-1.05), and those with public insurance (OR: 
2.07, 95%CI: 1.64-2.61) and private insurance (OR: 1.77, 95%CI: 1.36-2.31) were more 
likely to receive CCS compared to their younger and uninsured peers. Additionally, 
education level, income, usual source of health care, region, smoking status and 
BMI were all significant predictors of CCS. There were no significant changes in the 
rate of screening across the years assessed. CONCLUSIONS: Various predisposing, 
enabling, and need characteristics were identified as important predictors of CCS 
in women. Knowledge of these factors could be helpful in improving access to CCS, 
and consequently achieving the goals of Healthy People 2020 initiative.
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OBJECTIVES: There is limited evidence regarding the relationship between race/
ethnicity, health care quality, and hospital stays while the perceived quality of 
healthcare can impact health services utilization. We investigate race/ethnic dif-
ferences in the perceived quality of healthcare and the relationship with hospi-
talizations. METHODS: Using Medical Expenditure Panel Survey data for 2008 to 
2012, we analyzed data for adults aged 18 years and older, with at least one hospital 
stay and an evaluation using the Consumer Assessment of Healthcare Providers 
and Systems (CAHPS) quality measures. We defined healthcare quality using the 
CAHPS question that asked about the quality (10= best; 0= worst) of the health care 
received over the past 12 months. A probit regression model identified predictors of 
a high quality rating (8-10 vs. 0-7) and investigated the relationship between a high 
quality rating, race, and hospitalizations. We reported covariate-adjusted marginal 
effects. RESULTS: Application of inclusion criteria resulted in a sample of 10,892 
patients. The median age was 60 years and the race distribution was: 55% Caucasian, 
24% African American (AA), 16% Hispanic, and 5% Other. Hispanics were less likely 
(9%) than Whites to give high ratings to their providers while AA respondents were 
no more or less likely than Whites. The following factors were statistically signifi-
cantly associated with a high quality rating: high income, female gender, married 
status, and surgery patient. Following covariate adjustment, Whites and AA who 
rated their providers highly were more likely to be hospitalized (4% and 5% higher 
probability; p< 0.05) than those who did not rate their providers highly. Hispanics 
providing a high rating were less likely to be hospitalized (14% lower probability; 
p< 0.05) compared to those who did not give a high rating. CONCLUSIONS: We found 
significant differences between Hispanics and Whites in the perceived quality of 
health care with implications for the likelihood of a hospitalization.
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OBJECTIVES: Evidence-based, consensus-driven clinical pathways are increasingly 
recognized as a critical component of new delivery models and reimbursement 
methodologies including medical homes, accountable care organizations, episode-
of-care payment, and bundled payment. Providers may also have to negotiate mul-
tiple payer-specific pathways that are increasingly complex as a result of targeted 
precision medicine. Decision support tools (DST) have been considered one solution 
to navigate this complexity and optimize pathway compliance. We report on path-
way compliance variance related with or without use of a point-of-care, real-time 
oncology specific DST. METHODS: From 1/1/2012 to 12/31/2013, 38 oncologists from 
15 practices participating in a payer-sponsored oncologist-developed cancer path-
way program incorporated use of a proprietary real-time, point-of-care DST. Program 
participation and use of the DST was voluntary, but enhanced remuneration was 
provided to mitigate additional work. Retrospective data collection from fully adju-
dicated claims and from the DST was collected and compared quarterly from 10/1/12 
to 6/30/14. Physician chemotherapy regimen selections over the study period were 
reviewed for compliance to the consensus pathways. A 2-proportion z-test was used 
for data analysis. RESULTS: Of the 798 physician-generated chemotherapy selec-
tions ordered during the study period, 31% were registered in the point-of-care DST. 
